UNC45B

Chr 17ADAR

unc-45 myosin chaperone B

Also known as: CMYA4, CTRCT43, MFM11, SMUNC45, UNC-45B, UNC45

This gene encodes a co-chaperone required for folding and accumulation of type II myosins. The protein consists of three tetratricopeptide repeat motifs at the N-terminus that form a complex with heat shock protein 90, a central region of unknown function that is conserved in all Unc-45 proteins, and a C-terminal Unc-45/Cro1/She4 domain. The protein is expressed at high levels in striated muscle, where its muscle myosin chaperone activity is dependent on heat shock protein 90 acting as a co-chaperone. A missense mutation in this gene has been associated with cataract development. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015]

Primary Disease Associations & Inheritance

?Cataract 43MIM #616279
AD
Myofibrillar myopathy 11MIM #619178
AR
UniProtMyopathy, myofibrillar, 11
0
Active trials
13
Pathogenic / LP
406
ClinVar variants
5
Pubs (1 yr)
-0.4
Missense Z
0.91
LOEUF
Clinical SummaryUNC45B
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
13 Pathogenic / Likely Pathogenic· 218 VUS of 406 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.91LOEUF
pLI 0.000
Z-score 2.04
OE 0.67 (0.500.91)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
-0.40Z-score
OE missense 1.05 (0.981.12)
569 obs / 542.6 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.67 (0.500.91)
00.351.4
Missense OE1.05 (0.981.12)
00.61.4
Synonymous OE0.95
01.21.6
LoF obs/exp: 30 / 44.8Missense obs/exp: 569 / 542.6Syn Z: 0.61
DNGOF
DN
0.77top 25%
GOF
0.6932th %ile
LOF
0.3065th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

406 submitted variants in ClinVar

Classification Summary

Pathogenic10
Likely Pathogenic3
VUS218
Likely Benign100
Benign70
Conflicting5
10
Pathogenic
3
Likely Pathogenic
218
VUS
100
Likely Benign
70
Benign
5
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
3
7
0
10
Likely Pathogenic
0
2
1
0
3
VUS
2
202
13
1
218
Likely Benign
0
10
55
35
100
Benign
0
6
53
11
70
Conflicting
5
Total222312947406

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

UNC45B · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Gene2Phenotype Curations

UNC45B-related progressive myopathy with eccentric cores

strong
ARUndeterminedAltered Gene Product Structure
Dev. Disorders
G2P ↗
missense variantinframe deletioninframe insertion

UNC45B-related cataract

strong
ADUndeterminedAltered Gene Product Structure
Eye
G2P ↗
missense variantinframe deletioninframe insertion

Gene2Phenotype curations · DECIPHER consortium patient cohort (public variants) · deciphergenomics.org

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Landmark / reviewRecent case evidence